Carlsmed (CARL) Change in Receivables (2024 - 2026)

Carlsmed (CARL) has reported Change in Receivables for 3 consecutive years, with $2.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables rose 19.66% year-over-year to $2.2 million; the trailing twelve-month figure through Jun 2026 stood at $5.3 million (up 6.28% YoY), and the FY2025 full-year result was $5.0 million, up 26.23% from the prior year.
• Change in Receivables improved to $2.2 million in Q2 2026 per CARL's latest filing, from $1.3 million in the prior quarter.
• Across five years, Change in Receivables topped out at $2.2 million in Q2 2026 and bottomed at $98000.0 in Q3 2024.
• Historically, Change in Receivables has averaged $1.3 million across 3 years, with a median of $1.5 million in 2024.
• The widest YoY moves for Change in Receivables: up 1543.88% in 2025, down 92.64% in 2025.
• Over 3 years, Change in Receivables stood at $1.6 million in 2024, then sank by 92.64% to $117000.0 in 2025, then jumped by 1819.66% to $2.2 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $2.2 million, $1.3 million, and $117000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.